These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Lincoln DT; Singal PK; Al-Banaw A Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592 [TBL] [Abstract][Full Text] [Related]
8. Vascular stroma-derived endothelial colony forming progenitor cells adapt to tumour growth. Lincoln DT; Kaiser HE; Abul HT; al-Jarallah MA In Vivo; 2002; 16(6):479-92. PubMed ID: 12494892 [TBL] [Abstract][Full Text] [Related]
9. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation. Harting C; Peschke P; Borkenstein K; Karger CP Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335 [TBL] [Abstract][Full Text] [Related]
10. The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells. Mäkinen K; Loimas S; Nuutinen P; Eskelinen M; Alhava E Br J Cancer; 2000 Feb; 82(4):900-4. PubMed ID: 10732764 [TBL] [Abstract][Full Text] [Related]
11. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies. Christensen ME Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699 [TBL] [Abstract][Full Text] [Related]
12. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens. Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours. Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003 [TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers. Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752 [TBL] [Abstract][Full Text] [Related]
15. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor. Paulsen JE; Elgjo K In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236 [TBL] [Abstract][Full Text] [Related]
16. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours. Bignold LP Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890 [TBL] [Abstract][Full Text] [Related]
17. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins. Lee TK; Stupans I J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545 [TBL] [Abstract][Full Text] [Related]
18. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy. McAneney H; O'Rourke SF Phys Med Biol; 2007 Feb; 52(4):1039-54. PubMed ID: 17264369 [TBL] [Abstract][Full Text] [Related]
19. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Gasinska A; Fowler JF; Lind BK; Urbanski K Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186 [TBL] [Abstract][Full Text] [Related]
20. Decreased binding sites of angiotensin II in rat LY-80 and AH109A tumour and human gastric cancer using quantitative in vitro autoradiography. Kohzuki M; Tanda S; Hori K; Suzuki M; Yoshida K; Sato T Int Angiol; 2000 Mar; 19(1):52-8. PubMed ID: 10853686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]